https://www.selleckchem.com/pr....oducts/Flavopiridol.
Two-sample t-tests and chi-square tests were used for the bivariate analysis. Eighty patients were included (36 IUSVS and 44 EUSVS) with a mean follow-up of 7months. For our primary outcome, there was no difference in surgical success (IUSVS group 72.22% vs. EUSVS group 81.82%, p = 0.307). Operative time, duration of hospitalization, and EBL were significantly less in the EUSVS group than in the IUSVS group. EUSVS demonstrated similar short-term success compared to IUSVS for post-hysterectomy VVP, with shorter operative time, EBL,
Like
Comment
Share
